Clinical Trials Directory

Trials / Completed

CompletedNCT03759002

Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.

Association Between Mean Platelet Volume With Echocardiographic Indices and Carotid Intima Media Thickness in Children With End Stage Renal Disease.

Status
Completed
Phase
Study type
Observational
Enrollment
102 (actual)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Cardiovascular disease (CVD) is the major risk factor for death in end stage renal diseases (ESRD). Approximately 80% of ESRD patients have some degrees of left ventricular abnormalities at initiation of dialysis. Carotid intima media thickness (CIMT) has been widely accepted as an useful marker to assess CVD in ESRD children. In addition, cardiac mechanics parameters are used to evaluate cardiac function more precisely. However, measuring CIMT and cardiac mechanics parameters are expensive and difficult to perform as a routine method. Mean platelet volume (MPV) is a hematological index which shows the size of platelets. Uremic state causes inflammatory condition that affects MPV. Previous studies on people with normal renal function have shown that this parameter can also have association with CVD. However the data in children with ESRD is scarce. The aim of this study is to find a simple hematologic marker to use regularly in ESRD children finding patients at risk of CVD. Therefore, we will investigate the relationship between mean platelet volume and CIMT and cardiac mechanic parameters in children with ESRD.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTImagingImaging including Echocardiography for determining cardiac indices (ejection fraction, left ventricular mass index, strain rate, global longitudinal strain) and Doppler ultrasound for measuring carotid intima media thickness
OTHERBlood samplingBlood sampling will performed on all participants for measuring hematological parameters including MPV.

Timeline

Start date
2016-02-01
Primary completion
2018-02-01
Completion
2018-06-15
First posted
2018-11-29
Last updated
2018-11-29

Source: ClinicalTrials.gov record NCT03759002. Inclusion in this directory is not an endorsement.